2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Patient Involvement in Research: Ethical considerations and patient advocacy in research.
Patient involvement in cancer research is a vital aspect that ensures both ethical considerations and patient advocacy are prioritized. In recent years, there has been a growing recognition of the importance of integrating patient perspectives into the research process, from trial design to treatment outcomes. This involvement allows for a more patient-centered approach, ensuring that research is aligned with the needs and concerns of those directly affected by cancer. Ethical challenges arise when considering the risks patients face during clinical trials, as well as the need for informed consent, transparency, and respect for autonomy. Furthermore, patient advocacy groups play a critical role in promoting access to new treatments, providing emotional support, and ensuring that research is conducted with the patients' best interests in mind. Their involvement strengthens the ethical foundation of cancer research and improves the relevance of studies to real-world patient experiences.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China